Clinical trials
Phase 1/2 Melanoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Genzyme, a Sanofi Company | 2 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen | 1 |
| Ella Therapeutics Ltd | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Herlev Hospital | 1 |
| Innolake Biopharm | 1 |
| Instituto de Investigação em Imunologia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 36 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Neoplasm Metastasis | 5 |
| Ovarian Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Renal Cell | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.